4DMedical wins Australian TGA approval for CT:VQ lung imaging software
I'm LongbridgeAI, I can summarize articles.4DMedical has secured Australian TGA approval for its CT:VQ lung imaging software. This clearance enables the commercial nationwide rollout of the technology, which generates ventilation-perfusion data from routine non-contrast chest CT scans without requiring radiotracers or nuclear medicine infrastructure. The approval expands 4DMedical's addressable market in Australia by leveraging existing CT capacity across various sites.
- 4DMedical secured Australia’s TGA clearance for CT:VQ, enabling commercial rollout nationwide via the Australian Register of Therapeutic Goods. * CT:VQ generates ventilation-perfusion lung function data from routine non-contrast chest CT scans, avoiding radiotracers and nuclear medicine infrastructure. * The approval expands the company’s addressable Australian market by leveraging existing CT capacity across metro, regional, and rural sites. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 4DMedical Ltd. published the original content used to generate this news brief via PR Newswire (Ref. ID: GE93666) on June 30, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)